In brain, activation of astrocytes can induce calcium independent nitric oxide synthase (NOS-2) expression, which can contribute to the damage during ischemia, demyelinating disease, and viral infection. The applicants have previously characterized factors which activate astroglial NOS-2 expression, and two methods for potently blocking that expression, namely stimulation of b-ARs, and pretreatment with inhibitors of protein tyrosine kinases. They have also found that heat shock of glial cells reduces NOS-2 expression. Whether these methods of suppression represent distinct mechanisms, or share common features, is not known. Since activation of the transcription factor NFkB is required for NOS-2 expression, it is possible that all three suppressive means interfere with NFkB activation. This grant therefore proposes to test and characterize NFkB activation in astrocytes as it relates to NOS-2 induction. Differential NFkB activation by different inducers and/or in different cell types (e.g. astrocytes versus C6 cells) may explain differences in levels of NOS-2 induction. Since protein phosphorylation plays a key role in NFkB activation, the applicants will test if NE effects are mediated via a protein kinase, and if so if that kinase modifies NFkB activation. They will also test if NE induces IkB expression. They will fully characterize the heat shock response in astrocyte and C6 cells with the purpose of defining which heat shock proteins can block NOS-2 induction, and if that is due to blocking NFkB activation. They will test if heat shock proteins physically bind to the NFkB and/or IkB proteins, if they block IkB phosphorylation and/or degradation, or if they simply block NFkB movement into the nucleus. They will test if NE effects are due in part to induction of heat shock proteins. Some experiments (e.g. heat shock) will be carried out in animals to test if this suppressive method also works in vivo. These experiments will define multiple pathways to block NOS-2 expression that may be useful in preventing pathological NOS-2 expression in brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS031556-01A3
Application #
2037640
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1997-04-01
Project End
1997-11-30
Budget Start
1997-04-01
Budget End
1997-11-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Neurology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Madrigal, Jose L M; Feinstein, Douglas L; Dello Russo, Cinzia (2005) Norepinephrine protects cortical neurons against microglial-induced cell death. J Neurosci Res 81:390-6
Heneka, Michael T; Gavrilyuk, Vitaliy; Landreth, Gary E et al. (2003) Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J Neurochem 85:387-98
Bhat, Narayan R; Feinstein, Douglas L; Shen, Qin et al. (2002) p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription fact J Biol Chem 277:29584-92
Heneka, Michael T; Galea, Elena; Gavriluyk, Vitaliy et al. (2002) Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci 22:2434-42
Murphy, Patricia; Sharp, Anthony; Shin, Joseph et al. (2002) Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J Neurosci Res 67:461-70
Feinstein, D L; Murphy, P; Sharp, A et al. (2001) Local anesthetics potentiate nitric oxide synthase type 2 expression in rat glial cells. J Neurosurg Anesthesiol 13:99-105
Gavrilyuk, V; Horvath, P; Weinberg, G et al. (2001) A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 78:129-40
Heneka, M T; Feinstein, D L (2001) Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol 114:8-18
Heneka, M T; Sharp, A; Murphy, P et al. (2001) The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice. J Neurochem 77:568-79
Heneka, M T; Klockgether, T; Feinstein, D L (2000) Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci 20:6862-7

Showing the most recent 10 out of 11 publications